Page last updated: 2024-10-31

metyrapone and Anemia, Aplastic

metyrapone has been researched along with Anemia, Aplastic in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.

Research Excerpts

ExcerptRelevanceReference
"Three children with Fanconi's anemia belonging to a family where 6 children had the disease were investigated."1.25Fanconi's anemia. II. Are multiple endocrine insufficiencies a substantial part of the disease? ( Prindull, G; Stubbe, P, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stubbe, P1
Prindull, G1

Other Studies

1 other study available for metyrapone and Anemia, Aplastic

ArticleYear
Fanconi's anemia. II. Are multiple endocrine insufficiencies a substantial part of the disease?
    Acta paediatrica Scandinavica, 1975, Volume: 64, Issue:6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Anemia, Aplastic; Arginine; Blood Glucose; Body Height;

1975